Indication

Cerebral thromboembolism prevention

Cerebral thromboembolism prevention refers to therapeutic strategies aimed at averting the formation and migration of blood clots that can occlude the cerebral arterial circulation. Read more about Cerebral thromboembolism prevention

252 drugs 136 manufacturers

Advertisement

Drugs that treat it

Common Cerebral thromboembolism prevention therapies.

Showing 46–54 of 252 drugs

ASPIRIN EC (aspirin)

NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND SALICYLATES·MYOCARDIAL REINFARCTION PREVENTION·+11
SUNMARK

ASPIRIN

NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND SALICYLATES·MYOCARDIAL REINFARCTION PREVENTION·+11
PLUS PHARMA,INC

ASPIRIN

NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND SALICYLATES·MYOCARDIAL REINFARCTION PREVENTION·+11
PUBLIX SUPERMKT

ASPIRIN EC (aspirin)

NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND SALICYLATES·MYOCARDIAL REINFARCTION PREVENTION·+11
WEEKS & LEO CO.

ASPIRIN EC (aspirin)

NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND SALICYLATES·MYOCARDIAL REINFARCTION PREVENTION·+11
RITE AID CORP.

ASPIRIN EC (aspirin)

NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND SALICYLATES·MYOCARDIAL REINFARCTION PREVENTION·+11
EQUALINE VITAMI

ASPIRIN EC (aspirin)

NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND SALICYLATES·MYOCARDIAL REINFARCTION PREVENTION·+11
TIME-CAP LABS
Filter & compare in the drug finder →Opens the drug finder with Cerebral thromboembolism prevention preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Cerebral thromboembolism prevention.

Cerebral thromboembolism prevention refers to therapeutic strategies aimed at averting the formation and migration of blood clots that can occlude the cerebral arterial circulation.

This clinical goal primarily targets populations vulnerable to ischemic cerebrovascular events, such as patients with atrial fibrillation, mechanical heart valves, severe carotid atherosclerosis, or a prior history of transient ischemic attack or embolic stroke.

Pathophysiologically, the condition being prevented involves the disruption of intracranial perfusion when an intraluminal thrombus—originating from cardiac chambers, major proximal arteries, or paradoxical venous sources—dislodges and lodges in downstream cerebral vessels.

Without intervention, these occlusive events precipitate acute cerebral ischemia, cytotoxic edema, and irreversible neurological deficits characteristic of acute ischemic infarction.

Personalize your experience

Follow Cerebral thromboembolism prevention and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it